Latest News
-
Collaboration driving results
Posted on:
The Northern Sydney (Arabanoo) Precinct hosted its annual showcase at the Kolling, highlighting the innovative research between the Northern Sydney Local Health District and the University of Sydney. Launched in 2022 by Academic Directors Professors James Elliott, Robyn Gallagher and Margaret Schnitzler, the showcase focused on the joint research tackling complex healthcare challenges. Eight speakers
Category:
-
Innovation at the Kolling’s core
Posted on:
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who
Category:
-
Practical tool to offer better informed care for people living with dementia
Posted on:
Our researchers at the Kolling Institute are working to improve the use of medications for dementia with a comprehensive analysis highlighting several concerning trends. The latest data indicates more than 420,000 people are living with dementia in Australia, including more women than men. The condition is the second leading cause of death in Australia. Leading
-
Award raises profile of early career research at the Kolling Institute
Posted on:
Two of the Kolling Institute’s emerging leaders are gaining attention after receiving the ATA Scientific Encouragement Award. The award, which was launched more than a decade ago, aims to provide young scientists with financial assistance to further their education and attend scientific meetings and conferences. Scientific officer Kevin Winardi from the Kolling’s Lab of Ageing
-
Research driving the development of new implants and improving outcomes
Posted on:
Our researchers at the Kolling Institute have joined with international collaborators to develop a revolutionary implant for hip replacements. The ceramic implant, designed for hip resurfacing procedures, doesn’t require the long stem used in common hip replacements. This means surgeons are not removing the bone which they would generally remove for a hip replacement. Professor
Category:
-
Research to improve postmenopausal women’s bone and muscle health
Posted on:
Kolling Institute researchers Dr. Shejil Kumar and Professor Rory Clifton-Bligh have embarked on a pioneering study to enhance bone health in postmenopausal women. The study, titled “Combining Osteoanabolic Pharmacotherapy with Osteogenic Exercise in Postmenopausal Women with Osteoporosis and Osteopenia “The ROLEX-DUO Study,” is set to recruit 100 women aged 50 and above. The primary focus
-
Philanthropic funds launch crucial research into little-known cancer
Posted on:
Generous community support is strengthening our research into oesophageal cancer, lifting hopes of improved treatments for the aggressive and deadly cancer. The Fight for a Cure charity has donated $100,000 towards Dr Colby Stevenson’s research, on top of a $100,000 donation from the Howlett family, in memory of their son Scott who died from the
Category:
-
Leading new centre to strengthen cancer research and expertise
Posted on:
Researchers at the Kolling Institute have welcomed the launch of Australia’s premier cancer clinical trials centre on the Royal North Shore Hospital campus. NORTH Sydney Trials and Research Van Norton Poche or NORTH STAR VNP has been made possible by a $20 million gift from the late Kay Van Norton Poche and her husband Greg.
Category:
-
Crucial steps towards gene therapy for debilitating Meniere’s disease
Posted on:
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work. His
-
Researchers develop urine test based on kidney cell colour and AI to diagnose chronic kidney disease
Posted on:
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s